World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
112
Citations
50235
World Ranking
448
National Ranking
274

Medicine

D-Index
113
Citations
51229
World Ranking
4921
National Ranking
2666

Nick Andrews publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nick Andrews sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 533 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nick Andrews D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nick Andrews sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 112 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nick Andrews is affiliated with the Salk Institute for Biological Studies in the United States. Their primary field of study is Medicine, with a focus on various subfields including Infectious Diseases, Epidemiology, Health, Microbiology, and Modeling and Simulation.

The scientist's research topics emphasize SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, vaccine coverage and hesitancy, respiratory viral infections research, pneumonia and respiratory infections, influenza virus research studies, and bacterial infections and vaccines.

Nick Andrews has contributed to several recent publications related to COVID-19 and vaccines. These include:

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant, 2021, New England Journal of Medicine
  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study, 2021, BMJ
  • Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study., 2022, Bristol Research (University of Bristol)
  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study, 2021, The Lancet
  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN), 2021, The Lancet

Their frequent co-authors include Mary Ramsay, Jamie Lopez Bernal, Julia Stowe, Shamez Ladhani, and Gayatri Amirthalingam.

Nick Andrews publishes primarily in venues such as bioRxiv (Cold Spring Harbor Laboratory), Vaccine, Journal of Infection, Clinical Infectious Diseases, and SSRN Electronic Journal.

Best Publications

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

    Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

    James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  • Effectiveness of maternal pertussis vaccination in England: an observational study

    Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro

  • Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

    Elizabeth Miller;Katja Hoschler;Pia Hardelid;Elaine Stanford

  • Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

    Elizabeth Miller;Nicholas J Andrews;Pauline A Waight;Mary P E Slack

  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

    Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  • Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

    Caroline L Trotter;Nick J Andrews;Edward B Kaczmarski;Elizabeth Miller

  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

    V J Hall;S Foulkes;A Charlett;A Atti

  • Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

    Pauline A Waight;Nicholas J Andrews;Shamez N Ladhani;Carmen L Sheppard

  • Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40

    Wendy A. Knowles;Pam Pipkin;Nick Andrews;Andrew Vyse

  • Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.

    Simon de Lusignan;Simon de Lusignan;Jienchi Dorward;Jienchi Dorward;Ana Correa;Ana Correa;Nicholas Jones

  • Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

    Nick J Andrews;Pauline A Waight;Polly Burbidge;Emma Pearce

  • Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

    Shamez N Ladhani;Shamez N Ladhani;Sarah Collins;Abdelmajid Djennad;Carmen L Sheppard

  • Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

    Mary E Ramsay;Nick J Andrews;Caroline L Trotter;Edward B Kaczmarski

  • Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity

    Martin C. J. Maiden;Ana Belén Ibarz-Pavón;Rachel Urwin;Stephen J. Gray

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • A Statistical Algorithm for the Early Detection of Outbreaks of Infectious Disease

    C. P. Farrington;N. J. Andrews;A. D. Beale;M. A. Catchpole

  • Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

    Brent Taylor;Elizabeth Miller;Raghu Lingam;Nick Andrews

  • Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

    Mary E Ramsay;Nick Andrews;Edward B Kaczmarski;Elizabeth Miller

  • A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012–2013

    Gavin Dabrera;Gayatri Amirthalingam;Nick Andrews;Helen Campbell

  • Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. Commentary

    David S. Stephens;Martin C. J. Maiden;Ana Belén Ibarz-Pavon;Rachel Urwin

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Mary Ramsay
Mary Ramsay UK Health Security Agency
Richard Pebody
Richard Pebody Public Health England
Maria Zambon
Maria Zambon Public Health England
Elizabeth Miller
Elizabeth Miller London School of Hygiene & Tropical Medicine
Elizabeth Miller
Elizabeth Miller Stanford University
Joanna Ellis
Joanna Ellis Public Health England
Ray Borrow
Ray Borrow Manchester Royal Infirmary
Gayatri Amirthalingam
Gayatri Amirthalingam Public Health England
Norman K. Fry
Norman K. Fry Public Health England

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, pursuing specialized nursing programs can offer valuable career opportunities. One popular option is exploring the cheapest pmhnp programs online, which focus on psychiatric and mental health nursing. These affordable programs make advanced education accessible while addressing growing mental health care needs.

Additionally, individuals aiming for higher clinical roles might consider earning a Doctor of Nursing Practice degree. Exploring the doctor of nursing practice salary data nationwide can provide insight into potential earnings, highlighting the financial benefits linked to advanced practice roles.

For nurses wishing to broaden their skill set, an fnp to acnp bridge program online offers a streamlined pathway from family nurse practitioner to acute care nurse practitioner. This bridge program facilitates career growth in more specialized acute care settings.

Finally, accelerated pathways such as accelerated rn to np programs allow registered nurses to quickly advance to nurse practitioner roles. These online programs cater to working professionals seeking to fast-track their immunology-related clinical careers.

Best Scientists Citing Nick Andrews

Trending Scientists

Recently Published Articles